Clinical Trials Browser

Phase 3 × Leukemia, Myeloid, Acute × Lenalidomide × Clear all

NCT04490707 2022-03-24

Study of Azacytidine Combined With Lenalidomide As Maintenance Therapy Based on MRD Monitoring in AML

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute